Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study

Detalles Bibliográficos
Autores principales: Cooper, V, Horne, R, Ewan, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113045/
http://dx.doi.org/10.1186/1758-2652-13-S4-P42
_version_ 1782205875542294528
author Cooper, V
Horne, R
Ewan, J
author_facet Cooper, V
Horne, R
Ewan, J
author_sort Cooper, V
collection PubMed
description
format Online
Article
Text
id pubmed-3113045
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130452011-06-13 Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study Cooper, V Horne, R Ewan, J J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113045/ http://dx.doi.org/10.1186/1758-2652-13-S4-P42 Text en Copyright ©2010 Cooper et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Cooper, V
Horne, R
Ewan, J
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title_full Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title_fullStr Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title_full_unstemmed Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title_short Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
title_sort switching to atripla (efv/ftc/tdf) from kivexa (abc/3tc) plus efv leads to improved perceptions of treatment: results from the rocket 1 study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113045/
http://dx.doi.org/10.1186/1758-2652-13-S4-P42
work_keys_str_mv AT cooperv switchingtoatriplaefvftctdffromkivexaabc3tcplusefvleadstoimprovedperceptionsoftreatmentresultsfromtherocket1study
AT horner switchingtoatriplaefvftctdffromkivexaabc3tcplusefvleadstoimprovedperceptionsoftreatmentresultsfromtherocket1study
AT ewanj switchingtoatriplaefvftctdffromkivexaabc3tcplusefvleadstoimprovedperceptionsoftreatmentresultsfromtherocket1study

Ejemplares similares